Jeffrey Iwig

Title: The Innovative Contributions of Jeffrey Iwig

Introduction

Jeffrey Iwig is a notable inventor based in Albany, CA, who has made significant contributions to the field of pharmaceuticals. With a focus on developing innovative compounds, Iwig has been instrumental in advancing treatments for various medical conditions.

Latest Patents

Iwig holds 2 patents, showcasing his expertise in pharmaceutical chemistry. His latest patents include "N-cyano-7-azanorbornane derivatives and uses thereof," which provides a compound of formula (I) or a pharmaceutically acceptable salt thereof. This invention also details pharmaceutical compositions comprising the compound, methods for manufacturing these compounds, and their therapeutic uses. Another significant patent is for "KRAS G12C inhibitors and methods of using the same." This patent outlines inhibitors that are useful for treating disorders such as pancreatic, colorectal, and lung cancers.

Career Highlights

Iwig's career is marked by his dedication to research and development in the pharmaceutical industry. He works at Amgen Inc., a leading biotechnology company known for its innovative therapies. His work has contributed to the advancement of treatments that address critical health issues.

Collaborations

Throughout his career, Iwig has collaborated with esteemed colleagues, including Daniel A Erlanson and Joon Won Jeong. These collaborations have fostered an environment of innovation and have led to the development of groundbreaking therapies.

Conclusion

Jeffrey Iwig's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, making a significant impact on healthcare.